Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Warren

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The Lancet. Microbe|December 22, 2022
Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysisMichael B Hall, Marie Sylvianne Rabodoarivelo, Anastasia Koch, et al.
Emerging Infectious Diseases|February 24, 2021
Mycobacterium bovis Infection in Free-Ranging African ElephantsMichele A Miller, Tanya J Kerr, Candice R de Waal, et al.
Plos One|May 14, 2013
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South AfricaKaren Shean, Elizabeth Streicher, Elize Pieterson, et al.
Frontiers in Veterinary Science|February 22, 2019
Fatal Tuberculosis in a Free-Ranging African Elephant and One Health Implications of Human Pathogens in WildlifeMichele A Miller, Peter Buss, Eduard O Roos, et al.
Thorax|January 4, 2023
More than <i>Mycobacterium tuberculosis:</i> site-of-disease microbial communities, and their functional and clinical profiles in tuberculous lymphadenitisGeorgina R Nyawo, Charissa C Naidoo, Benjamin Wu, et al.
Microbes and Infection|November 11, 2024
Bad company? The pericardium microbiome in people investigated for tuberculous pericarditis in an HIV-prevalent settingGeorgina Nyawo, Charissa C Naidoo, Benjamin G Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Bad company? The pericardium microbiome in people investigated for tuberculosis pericarditis in an HIV-prevalent settingGeorgina Nyawo, Charissa Naidoo, Benjamin G Wu, et al.
BMC Genomics|May 20, 2026
Evaluation of DNA extraction methods from clinical Mycobacterium tuberculosis primary liquid culture for whole-genome sequencingEmilyn Costa Conceição, Mishka Haffejee, Felicia Wells, et al.
American Journal of Respiratory and Critical Care Medicine|February 17, 2022
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)Aliasgar Esmail, Suzette Oelofse, Carl Lombard, et al.
The Lancet. Microbe|November 6, 2023
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort studyBrigitta Derendinger, Anzaan Dippenaar, Margaretha de Vos, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Lancet. Microbe|December 22, 2022
Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysisMichael B Hall, Marie Sylvianne Rabodoarivelo, Anastasia Koch, et al.
Emerging Infectious Diseases|February 24, 2021
Mycobacterium bovis Infection in Free-Ranging African ElephantsMichele A Miller, Tanya J Kerr, Candice R de Waal, et al.
Plos One|May 14, 2013
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South AfricaKaren Shean, Elizabeth Streicher, Elize Pieterson, et al.
Frontiers in Veterinary Science|February 22, 2019
Fatal Tuberculosis in a Free-Ranging African Elephant and One Health Implications of Human Pathogens in WildlifeMichele A Miller, Peter Buss, Eduard O Roos, et al.
Thorax|January 4, 2023
More than <i>Mycobacterium tuberculosis:</i> site-of-disease microbial communities, and their functional and clinical profiles in tuberculous lymphadenitisGeorgina R Nyawo, Charissa C Naidoo, Benjamin Wu, et al.
Microbes and Infection|November 11, 2024
Bad company? The pericardium microbiome in people investigated for tuberculous pericarditis in an HIV-prevalent settingGeorgina Nyawo, Charissa C Naidoo, Benjamin G Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Bad company? The pericardium microbiome in people investigated for tuberculosis pericarditis in an HIV-prevalent settingGeorgina Nyawo, Charissa Naidoo, Benjamin G Wu, et al.
BMC Genomics|May 20, 2026
Evaluation of DNA extraction methods from clinical Mycobacterium tuberculosis primary liquid culture for whole-genome sequencingEmilyn Costa Conceição, Mishka Haffejee, Felicia Wells, et al.
American Journal of Respiratory and Critical Care Medicine|February 17, 2022
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)Aliasgar Esmail, Suzette Oelofse, Carl Lombard, et al.
The Lancet. Microbe|November 6, 2023
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort studyBrigitta Derendinger, Anzaan Dippenaar, Margaretha de Vos, et al.
Pageof 8